Personas / Equipo Humano

Silvia Simó Nebot

Buscador de publicaciones

Publicaciones

  • Font A, Agüera M, Rios-Barnés M, Gamell Fullà A, Moreno-Romo D, López-Ramos MG, Manuel Monsonis Cabedo, Fumadó V, Simó-Nebot S, García-Fontecha CG, Fortuny-Guasch C, Echeverría-Esnal D, Noguera-Julian A and Velasco E.

    Impact of paediatric antimicrobial stewardship program in haematogenous bone and joint infections.

    EUROPEAN JOURNAL OF PEDIATRICS . 184(7): 426-426.

    [doi:10.1007/s00431-025-06258-7]

  • Noguera-Julian A, Wilhelmi E, Cussó M, Aarnoutse R, Colbers A, Martorell-Sampol L, López-Ramos MG, Vinent-Genestar J, Rosa Farré Riba, Soy D, Simó-Nebot S and Fortuny-Guasch C.

    Pharmacokinetic Analysis of an Isoniazid Suspension Among Spanish Children Under 6 Years of Age

    ANTIBIOTICS-BASEL . 14(1): .

    [doi:10.3390/antibiotics14010074]

  • Pons-Tomàs G, Irene Martínez de Albéniz, Rios-Barnés M, Gamell Fullà A, Simó-Nebot S, Balsells S, Hernández-García M, Melé-Casas M, Sánchez E, Manuel Monsonis Cabedo, Gene-Giralt A, López M, Salvia D, García-García JJ, Fortuny-Guasch C and Fumadó V.

    Serological Outcome in the First Months of Life of Children Born to Mothers with SARS-CoV-2 Infection during Pregnancy

    CHILDREN-BASEL . 11(9): .

    [doi:10.3390/children11091095]

  • Gamell Fullà A, Velasco E, López-Ramos MG, Rios-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julian A and Fortuny-Guasch C.

    Off-label use of dalbavancin in children: a case series

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 79(8): 2062-2067. Nº de citas: 2

    [doi:10.1093/jac/dkae212]

  • Monzó-Gallo P, Chumbita M, Lopera C, Aiello TF, Peyrony O, Bodro M, Herrera S, Sempere A, Fernández-Pittol M, Cuesta G, Simó-Nebot S, Benegas M, Fortuny-Guasch C, Mensa J, Soriano A, Puerta-Alcalde P, Marco F and Garcia-Vidal C.

    Real-life epidemiology and current outcomes of hospitalized adults with invasive fungal infections.

    MEDICAL MYCOLOGY . 61(3): . Nº de citas: 11

    [doi:10.1093/mmy/myad021]

  • Margarit-Soler A, Deyà-Martinez A, Canizales JT, Vlagea A, García-García AP, Marsal-Ricoma J, Del Castillo MT, Planas-Roman S, Simó-Nebot S, Esteve-Solé A, Grande MS, Badell-Serra I, Tarrats MR, Fernández-Avilés F and Alsina L.

    Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders

    FRONTIERS IN IMMUNOLOGY . 13: 1070068-1070068. Nº de citas: 4

    [doi:10.3389/fimmu.2022.1070068]

  • Velasco E, Batllori-Tragant M, Manuel Monsonis Cabedo, Valls-Lafon A, Rios-Barnés M, Simó-Nebot S, Gamell Fullà A, Fortuny-Guasch C, Tebruegge M and Noguera-Julian A.

    Host, technical, and environmental factors affecting QuantiFERON-TB Gold In-Tube performance in children below 5 years of age

    SCIENTIFIC REPORTS . 12(1): 19908-19908. Nº de citas: 3

    [doi:10.1038/s41598-022-24433-w]

  • Simó-Nebot S, López-Ramos MG, Velasco E, Jordán-García I, Fortuny-Guasch C and Noguera-Julian A.

    Impact and quality of antimicrobial use in a referral pediatric intensive care unit.

    enfermedades infecciosas y microbiologia clinica (english ed.) . 40(2): 78-81.

    [doi:10.1016/j.eimce.2021.05.013]

  • Simó-Nebot S, López-Ramos MG, Velasco E, Jordán-García I, Fortuny-Guasch C and Noguera-Julian A.

    Impact and quality of antimicrobial use in a referral pediatric intensive care unit

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 40(2): 78-81. Nº de citas: 6

    [doi:10.1016/j.eimc.2021.05.001]

  • Castany-Feixas M, Simó-Nebot S, Garcia-Garcia S, Fernández de Sevilla-Estrach M, Launes-Montana C, Kalkgruber M, Gene-Giralt A, Munoz-Almagro C and Brotons-de los Reyes P.

    Rapid molecular syndromic testing for aetiological diagnosis of gastrointestinal infections and targeted antimicrobial prescription: experience from a reference paediatric hospital in Spain

    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES . 40(10): 2153-2160. Nº de citas: 10

    [doi:10.1007/s10096-021-04266-7]